[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:rem-sleep-behavior-disorder":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":92,"states":93},"REM sleep behavior disorder",13,7,[8,15,22,28,34,40,46,52,60,66,73,80,86],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT06441864","Behavioral Treatment for Nightmares in REM Sleep Behavior Disorder",[],"RECRUITING","2026-08-26T02:16:35.654046Z","2026-04-29T02:57:57.155917Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06996652","An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)",[19],"Phase 2","2026-08-26T02:18:44.395098Z","2026-07-05T05:32:16.729817Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT07217054","Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder",[],"2026-08-26T02:19:23.493898Z","2026-05-13T02:55:06.673857Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT06329453","Intestinal Immunity in Neurologic Disease",[],"2026-08-26T02:17:35.666428Z","2026-05-13T02:55:06.436456Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":38,"content_modified":39},"NCT01799915","Natural History Study of Synucleinopathies",[],"2026-08-26T02:19:14.560989Z","2026-05-13T02:55:06.077141Z",{"nct_id":41,"title":42,"phases":43,"status":12,"updated_at":44,"content_modified":45},"NCT05471960","Neuroplasticity in RBD",[],"2026-08-26T02:16:01.079019Z","2026-05-05T02:35:31.915675Z",{"nct_id":47,"title":48,"phases":49,"status":12,"updated_at":50,"content_modified":51},"NCT06467461","Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder",[],"2026-08-03T03:38:39.261584Z","2026-05-05T02:43:28.509363Z",{"nct_id":53,"title":54,"phases":55,"status":57,"updated_at":58,"content_modified":59},"NCT06644573","Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia",[56],"Phase 1","NOT_YET_RECRUITING","2026-08-26T02:18:46.948970Z","2026-05-05T02:43:29.362542Z",{"nct_id":61,"title":62,"phases":63,"status":57,"updated_at":64,"content_modified":65},"NCT07288593","INSIGHT: Insomnia, Nightmares, and Sympathetic Hyperactivity Intervention",[],"2026-08-26T02:17:05.997056Z","2026-05-05T02:43:26.945337Z",{"nct_id":67,"title":68,"phases":69,"status":70,"updated_at":71,"content_modified":72},"NCT03623672","North American Prodromal Synucleinopathy Consortium",[],"ENROLLING_BY_INVITATION","2026-08-26T02:15:24.145250Z","2026-06-16T05:54:07.968563Z",{"nct_id":74,"title":75,"phases":76,"status":70,"updated_at":78,"content_modified":79},"NCT05514106","MIBG in Aging and Neurologic Disorders",[77],"Phase 4","2026-08-26T02:15:22.311223Z","2026-06-16T05:54:08.079315Z",{"nct_id":81,"title":82,"phases":83,"status":70,"updated_at":84,"content_modified":85},"NCT01453127","DaTSCAN Imaging in Aging and Neurodegenerative Disease",[77],"2026-08-26T02:18:43.501109Z","2026-06-16T05:54:07.946347Z",{"nct_id":87,"title":88,"phases":89,"status":70,"updated_at":90,"content_modified":91},"NCT05826457","North American Prodromal Synucleinopathy Consortium Stage 2",[],"2026-08-26T02:17:57.997171Z","2026-05-13T02:55:06.379597Z",[],[94,98,102,106,109,112,115],{"state":95,"count":96,"slug":97},"Minnesota",9,"minnesota",{"state":99,"count":100,"slug":101},"Massachusetts",4,"massachusetts",{"state":103,"count":104,"slug":105},"California",3,"california",{"state":107,"count":104,"slug":108},"Connecticut","connecticut",{"state":110,"count":104,"slug":111},"Georgia","georgia",{"state":113,"count":104,"slug":114},"Missouri","missouri",{"state":116,"count":104,"slug":117},"Oregon","oregon"]